Peter Brossart
Impact in
- Hematology top 0.2%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Immunology top 0.2%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
Papers in
- Immunology 135
- Immunotherapy and Immune Responses 99
- Immune Cell Function and Interaction 42
- T-cell and B-cell Immunology 32
- Hematology 78
- Acute Myeloid Leukemia Research 26
- Chronic Myeloid Leukemia Treatments 25
- Multiple Myeloma Research and Treatments 24
- Co-authors
- Frank Grünebach (55 shared papers)Annkristin Heine (53 shared papers)Lothar Kanz (38 shared papers)Wolfram Brugger (29 shared papers)Alessio Nencioni (22 shared papers)Michael John Bevan (6 shared papers)Volker L. Reichardt (18 shared papers)Gernot Stuhler (13 shared papers)
- Journals
- Blood (59 papers)Leukemia (22 papers)Clinical Cancer Research (11 papers)Cancer Immunology Immunotherapy (11 papers)The Journal of Immunology (7 papers)
- Partner nations
- GermanyUnited StatesItaly
In The Last Decade
Peter Brossart
330 papers receiving 15.7k citations
Peter Brossart's Hit Papers
Peers
Comparison fields: 5 of 143
- Hematology 3.6k
- Immunology 6.5k
- Oncology 4.5k
- Genetics 1.7k
- Molecular Biology 5.8k
Countries citing papers authored by Peter Brossart
This map shows the geographic impact of Peter Brossart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Brossart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Brossart more than expected).
Fields of papers citing papers by Peter Brossart
This network shows the impact of papers produced by Peter Brossart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Brossart. The network helps show where Peter Brossart may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Brossart, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 336 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 466 | |
| 2 | G-quadruplexes: a promising target for cancer therapy Hit paper breakdown → | 2021 | 404 |
| 3 | Differential impact of allelic ratio and insertion site in FLT3-ITD–positive AML with respect to allogeneic transplantation Hit paper breakdown → | 2014 | 346 |
| 4 | 2016 | 308 | |
| 5 | 2013 | 302 | |
| 6 | 1999 | 270 | |
| 7 | 2017 | 260 | |
| 8 | 2008 | 250 | |
| 9 | Virus-mediated delivery of antigenic epitopes into dendritic cells as a means to induce CTL. | 1997 | 228 |
| 10 | 2003 | 222 | |
| 11 | 2016 | 218 | |
| 12 | 1997 | 211 | |
| 13 | 2019 | 198 | |
| 14 | Her-2/neu-derived peptides are tumor-associated antigens expressed by human renal cell and colon carcinoma lines and are recognized by in vitro induced specific cytotoxic T lymphocytes. | 1998 | 195 |
| 15 | 2006 | 193 | |
| 16 | 2010 | 190 | |
| 17 | 2006 | 189 | |
| 18 | 2015 | 188 | |
| 19 | 1997 | 187 | |
| 20 | The epithelial tumor antigen MUC1 is expressed in hematological malignancies and is recognized by MUC1-specific cytotoxic T-lymphocytes. | 2001 | 180 |
About Peter Brossart
Peter Brossart is a scholar working on Immunology, Hematology, Oncology, Genetics and Molecular Biology, having authored 336 papers that have together received 16.0k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (99 papers), Immune Cell Function and Interaction (42 papers), Cancer Immunotherapy and Biomarkers (38 papers), T-cell and B-cell Immunology (32 papers), CAR-T cell therapy research (30 papers), Acute Myeloid Leukemia Research (26 papers), Chronic Myeloid Leukemia Treatments (25 papers) and Multiple Myeloma Research and Treatments (24 papers). The work is most often cited by research in Hematology (3.6k citations), Immunology (6.5k citations), Oncology (4.5k citations), Genetics (1.7k citations) and Molecular Biology (5.8k citations). Peter Brossart has collaborated with scholars based in Germany, United States and Italy. Frequent co-authors include Frank Grünebach, Annkristin Heine, Lothar Kanz, Wolfram Brugger, Alessio Nencioni, Michael John Bevan, Volker L. Reichardt, Gernot Stuhler, Markus M. Weck and Martin Müller. Their work appears in journals such as Blood, Leukemia, Clinical Cancer Research, Cancer Immunology Immunotherapy and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.